Screener
CG Oncology CGON Total Liabilities Assumed in Business Combination
Total Liabilities Assumed in Business Combination at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's total liabilities assumed in business combination?
- CG Oncology (CGON) reported total liabilities assumed in business combination of $307K in Q2 2026.
- What does total liabilities assumed in business combination mean?
- This metric represents the total value of obligations and debts acquired by the company as a result of an acquisition or merger transaction. It reflects the liabilities transferred from the acquired entity to the company's balance sheet at the time of the business combination. Monitoring this figure is essential for assessing the impact of inorganic growth strategies on the company's overall leverage and long-term financial risk profile.
Ask your AI about CG Oncology's total liabilities assumed in business combination.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude